Unibest 优贝德
← Back to patent-cliff list

CAS 2730017-99-7

(3aS,8S,9S,13S,13aS,13bS)-13-(Benzyloxy)-2,2,5,10,13a,14,14-heptamethyl-6,7,9,11,12,13,13a,13b-octahydro-2H-4,8-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxole-8,9(3aH)-diol

Codes:(XII)101438-71-a

Application context (from source-drug indications)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Paclitaxel/Encequidar mesylate优化路线steps: 11total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.